204 related articles for article (PubMed ID: 19793106)
41. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
[TBL] [Abstract][Full Text] [Related]
42. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
[TBL] [Abstract][Full Text] [Related]
43. Pulmonary vasodilation by phosphodiesterase 5 inhibition is enhanced and nitric oxide independent in early pulmonary hypertension after myocardial infarction.
van Duin RWB; Houweling B; Uitterdijk A; Duncker DJ; Merkus D
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H170-H179. PubMed ID: 28986358
[TBL] [Abstract][Full Text] [Related]
44. 8-isoprostane F2α up-regulates the expression of type 5 phosphodiesterase in cavernosal vascular smooth muscle cells: inhibition with sildenafil, iloprost, nitric oxide and picotamide.
Hotston M; Jeremy JY; Persad R; Bloor J; Shukla N
BJU Int; 2010 Dec; 106(11):1794-8. PubMed ID: 20500512
[TBL] [Abstract][Full Text] [Related]
45. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters.
Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F
Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559
[TBL] [Abstract][Full Text] [Related]
46. Exogenous l-ARGININE does not stimulate production OF NO or cGMP within the rat corporal smooth muscle cells in culture.
Ferrini MG; Abraham A; Nguyen S; Luna R; Flores M; Artaza JN; Graciano L; Rajfer J
Nitric Oxide; 2019 Aug; 89():64-70. PubMed ID: 31075315
[TBL] [Abstract][Full Text] [Related]
47. Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension.
Tan X; Chai J; Bi SC; Li JJ; Li WW; Zhou JY
Vet J; 2012 Aug; 193(2):420-5. PubMed ID: 22377328
[TBL] [Abstract][Full Text] [Related]
48. Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression.
Sapienza P; Borrelli V; Sterpetti AV; Dinicola S; Tartaglia E; di Marzo L
Ann Vasc Surg; 2011 Aug; 25(6):823-9. PubMed ID: 21620672
[TBL] [Abstract][Full Text] [Related]
49. Endothelin-1 augments Na⁺/H⁺ exchange activity in murine pulmonary arterial smooth muscle cells via Rho kinase.
Undem C; Rios EJ; Maylor J; Shimoda LA
PLoS One; 2012; 7(9):e46303. PubMed ID: 23029469
[TBL] [Abstract][Full Text] [Related]
50. New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
Abid S; Kebe K; Houssaïni A; Tomberli F; Marcos E; Bizard E; Breau M; Parpaleix A; Tissot CM; Maitre B; Lipskaia L; Derumeaux G; Bastia E; Mekontso-Dessap A; Adnot S
J Cardiovasc Pharmacol; 2018 May; 71(5):283-292. PubMed ID: 29438213
[TBL] [Abstract][Full Text] [Related]
51. Effects of folic acid and magnesium on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells.
Guo H; Lee JD; Uzui H; Yue H; Wang J; Toyoda K; Geshi T; Ueda T
Circ J; 2006 Jan; 70(1):141-6. PubMed ID: 16377938
[TBL] [Abstract][Full Text] [Related]
52. Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways.
Doronzo G; Russo I; Mattiello L; Trovati M; Anfossi G
Thromb Haemost; 2005 Dec; 94(6):1285-93. PubMed ID: 16411407
[TBL] [Abstract][Full Text] [Related]
53. Possible involvement of Cyclic-GMP-dependent protein kinase on matrix metalloproteinase-2 expression in rat aortic smooth muscle cells.
Dey NB; Lincoln TM
Mol Cell Biochem; 2012 Sep; 368(1-2):27-35. PubMed ID: 22618526
[TBL] [Abstract][Full Text] [Related]
54. Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells.
Farrow KN; Groh BS; Schumacker PT; Lakshminrusimha S; Czech L; Gugino SF; Russell JA; Steinhorn RH
Circ Res; 2008 Feb; 102(2):226-33. PubMed ID: 17991881
[TBL] [Abstract][Full Text] [Related]
55. C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells.
Doronzo G; Russo I; Mattiello L; Trovati M; Anfossi G
J Lab Clin Med; 2005 Nov; 146(5):287-98. PubMed ID: 16242528
[TBL] [Abstract][Full Text] [Related]
56. Phosphodiesterase 1 regulation is a key mechanism in vascular aging.
Bautista Niño PK; Durik M; Danser AH; de Vries R; Musterd-Bhaggoe UM; Meima ME; Kavousi M; Ghanbari M; Hoeijmakers JH; O'Donnell CJ; Franceschini N; Janssen GM; De Mey JG; Liu Y; Shanahan CM; Franco OH; Dehghan A; Roks AJ
Clin Sci (Lond); 2015 Dec; 129(12):1061-75. PubMed ID: 26464516
[TBL] [Abstract][Full Text] [Related]
57. Metal ion stimulators of PDE5 cause similar conformational changes in the enzyme as does cGMP or sildenafil.
Corbin JD; Foster TL; Bessay E; Busch J; Blount M; Francis SH
Cell Signal; 2011 May; 23(5):778-84. PubMed ID: 21187142
[TBL] [Abstract][Full Text] [Related]
58. Endothelial dysfunction enhances the pulmonary and systemic vasodilator effects of phosphodiesterase-5 inhibition in awake swine at rest and during treadmill exercise.
Houweling B; Quispel J; Beier N; Verdouw PD; Duncker DJ; Merkus D
Exp Biol Med (Maywood); 2012 Feb; 237(2):201-10. PubMed ID: 22312057
[TBL] [Abstract][Full Text] [Related]
59. RhoA increases ASIC1a plasma membrane localization and calcium influx in pulmonary arterial smooth muscle cells following chronic hypoxia.
Herbert LM; Resta TC; Jernigan NL
Am J Physiol Cell Physiol; 2018 Feb; 314(2):C166-C176. PubMed ID: 29070491
[TBL] [Abstract][Full Text] [Related]
60. Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1.
Murthy KS
Br J Pharmacol; 2008 Mar; 153(6):1214-24. PubMed ID: 18204475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
